Rtm. Vandongen et al., MORPHINE AND MORPHINE-GLUCURONIDE CONCENTRATIONS IN PLASMA AND CSF DURING LONG-TERM ADMINISTRATION OF ORAL MORPHINE, British journal of clinical pharmacology, 38(3), 1994, pp. 271-273
Concentrations of morphine, morphine-3-glucuronide (M3G) and morphine-
6-glucuronide (M6G) were measured by h.p.l.c. in plasma and cerebrospi
nal fluid (CSF) samples from 16 patients with cancer receiving oral (c
ontrolled-release) morphine. There was a close correlation between pla
sma and CSF morphine concentrations (r = 0.94, P = 0.0001) and both co
rrelated with drug dosage (r = 0.61, P = 0.013 and r = 0.74, P = 0.000
1, respectively). M3G and M6G in plasma and CSF were correlated (r = 0
.81 and r = 0.82, both P = 0.0001). No relationship was apparent betwe
en M plus M6G concentrations in the CSF and pain scores.